THE FEMINIST HEALTH CIC

Company limited by guarantee

Company Registration Number:
15377317 (England and Wales)

Unaudited statutory accounts for the year ended 31 December 2024

Period of accounts

Start date: 31 December 2023

End date: 31 December 2024

THE FEMINIST HEALTH CIC

Contents of the Financial Statements

for the Period Ended 31 December 2024

Profit and loss
Balance sheet
Additional notes
Balance sheet notes
Community Interest Report

THE FEMINIST HEALTH CIC

Profit And Loss Account

for the Period Ended 31 December 2024

2024


£
Turnover: 1,464
Cost of sales: ( 653 )
Gross profit(or loss): 811
Administrative expenses: ( 992 )
Operating profit(or loss): (181)
Profit(or loss) before tax: (181)
Profit(or loss) for the financial year: (181)

THE FEMINIST HEALTH CIC

Balance sheet

As at 31 December 2024

Notes 2024


£
Current assets
Cash at bank and in hand: 598
Total current assets: 598
Creditors: amounts falling due within one year: 3 ( 780 )
Net current assets (liabilities): (182)
Total assets less current liabilities: (182)
Total net assets (liabilities): (182)
Members' funds
Profit and loss account: (182)
Total members' funds: ( 182)

The notes form part of these financial statements

THE FEMINIST HEALTH CIC

Balance sheet statements

For the year ending 31 December 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 17 September 2025
and signed on behalf of the board by:

Name: Ifeoma Nneka Emelurumonye
Status: Director

The notes form part of these financial statements

THE FEMINIST HEALTH CIC

Notes to the Financial Statements

for the Period Ended 31 December 2024

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

THE FEMINIST HEALTH CIC

Notes to the Financial Statements

for the Period Ended 31 December 2024

  • 2. Employees

    2024
    Average number of employees during the period 0

THE FEMINIST HEALTH CIC

Notes to the Financial Statements

for the Period Ended 31 December 2024

3. Creditors: amounts falling due within one year note

2024
£
Other creditors 780
Total 780

COMMUNITY INTEREST ANNUAL REPORT

THE FEMINIST HEALTH CIC

Company Number: 15377317 (England and Wales)

Year Ending: 31 December 2024

Company activities and impact

The Feminist Health CIC places particular emphasis on raising women’s health knowledge and addressing health inequalities. The company activities have benefitted the community in the following ways: -3 online webinars with health professionals (General Practitioner, Oncologist and Dentist) dedicate to the specific topic of women health, oral health during pregnancy and cancer screening of interest of women -1 in person event with consultant in gynaecology dedicate to cancer screening, fertility and menstrual health -Organization of the first Italian Summit of Black and Africa Diaspora of Health Professional with the aim to provide a space of reflection and collaboration to address health inequalities faced by Black and African communities in Italy, with focus on women, children and young people and mental health -Stakeholder participation to development of the Italian anti-racism manifesto presented to the Italian Senate. The company contributed in defining recommendation on addressing racism in the healthcare also with an intersectional perspective -Monthly newsletter about the company activity

Consultation with stakeholders

The company’s stakeholders are residents both in the UK, Italy and Africa and include health professionals, local authorities, voluntary sectors, universities and other partners. The director has lived in Italy and UK, has an African background that has helped to develop networking collaborations to support the company’s work. We held a consultation during the summit, of which 80 participants participated between students and clinician. The survey evaluation was completed by 18 respondents providing the results below: - 100% were satisfied, with 725 very satisfied - 89% rated the event as well organized - Speakers: 50% excellent, 44% good, 6% satisfactory - 83% found content directly relevant to interests - 72% reported sufficient network opportunities - 94% would attend a future edition Amongst the qualitative themes of open-text feedback, stakeholders highlighted the event as “powerful”, “inspiring” and “necessary”.

Directors' remuneration

No remuneration was received

Transfer of assets

No transfer of assets other than for full consideration

This report was approved by the board of directors on
17 September 2025

And signed on behalf of the board by:
Name: Ifeoma Nneka Emelurumonye
Status: Director